CLINICAL_TRIALS
trial_result
· 2025-07-31
Clinical Trial Update: Topical Ruxolitinib Evaluation in Chronic Hand Eczema [Phase 2]
Summary
A Phase 2 trial evaluating topical ruxolitinib for chronic hand eczema has completed, and its results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Incyte Corporation | Conditions: Hand Eczema | Phase 2 | Status: COMPLETED | Results posted: 2025-07-31